Non-Ultradian Cardiac Rhythms: Circadian Regulation of the Heart by Stephen Karaganis
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
5 
Non-Ultradian Cardiac Rhythms:  
Circadian Regulation of the Heart 
Stephen Karaganis 
Parker University   
USA 
1. Introduction  
The heart undergoes relentless biophysical oscillations over the course of a life span in order 
to sustain life. The heart’s continuous rhythm of beating consists of sustained, serial 
oscillations in ionic currents, membrane potential, and excitation-contraction coupling. The 
rhythm of its beats expresses a period range of 0.6-1 seconds in healthy adults. These high 
frequency ultradian (< 24 hr period) rhythms are the life blood of the body’s most important 
myogenic oscillator and pump. However, these are not the only rhythms vital to the 
function of cadiac tissue, as the heart and other components of the cardiovascular system are 
under control of the body’s circadian clock. This “clock“ is not a singular entity, but rather 
consists of distributed oscillators which impose numerous biochemical and physiological 
rhythms with a periodicity of approximately 24 hours. Indeed, recent evidence has 
demonstrated that the very cells of the heart are circadian oscillators themselves.      
Numerous studies of animal models, including humans, reveal that multiple processes of 
cardiac physiology are under control by the circadian system. Moreover, circadian control 
by the organismal “clock” encompasses multiple layers of regulation, extending, at its most 
reduced level, to the molecular clockworks residing within individual cardiomyocytes (Bray 
et al., 2008) and other cardiac cell types (Young, 2009). Coupling between cardiomyocytes at 
the tissue level results in a synchronized cardiac organ-clock. The cardiac clock functions in 
a semiautonomous manner in isolation from autonomic and humoral inputs. These 
“exogenous” inputs represent regulatory arms of the larger circadian system to which the 
cardiac clock is subject to control. The neurohumoral arms of the circadian system are 
driven by the neurocephalic circadian axis, the most important component of which (at least 
in mammals) resides in the suprachiasmatic nuclei of the hypothalamus. However, other 
cephalic components, including the eye and pineal, reinforce central and peripheral 
oscillations and maintain coupling between them, as well as with true exogenous factors 
such as light and dietary intake (Bell-Pedersen et al., 2005; Stratmann and Schibler, 2006). 
Together, these multiple systems interact to produce overt rhythms in cardiac physiology 
including rhythms of heart rate, contraction force, blood pressure, metabolism, gene 
expression, and more (Young, 2009). 
Of particular clinical interest is the observation that multiple aspects of cardiac pathology 
fluctuate on a circadian basis. Numerous studies have documented daily oscillations in 
the occurrence of pathologic cardiac events (Elliott, 2001; Mahmoud at al., 2011). The 
collective impact of these time-of-day-dependent phenomena on human welfare and 
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economics is likely enormous, though the etiology of this temporal dependence is not 
fully understood. Elucidation of the mechanisms underlying these time-dependent 
phenomena is no doubt complicated by the complex, hierarchical organization of the 
circadian system and its far-reaching presence across most tissues. In fact, it is not always 
clear what direct role circadian regulation plays in rhythmic features of cardiac 
physiology and pathology compared to indirect effects which may propagate between 
coupled organ systems. Moreover, not all such rhythms may necessarily be attributed to 
endogenous circadian control at all; rather, some rhythms may be driven independently 
by oscillating exposure to environmental factors themselves and not as zeitgebers 
(timekeepers or entrainment cues). 
Understanding the role of the circadian system as a primary regulator of daily changes in 
cardiac physiology and pathophysiology is of both extreme scientific and clinical interest. 
Development of new therapeutic modalities, as well as improving standard ones, will require 
an unraveling of these intertwined regulatory processes, both direct and indirect, internal and 
external. This necessitates a deeper characterization of the role of circadian processes at 
multiple levels of cardiac function, from the cellular and molecular levels to the systems and 
organismal levels. The aim of this chapter, therefore, is to review the ever-increasing wealth of 
data on circadian control of the heart obtained from human and non-human animal models. I 
will explore many of the major findings to date at each hierarchical level of control to provide 
a broad view of how the circadian system regulates the physiology of the heart, contributes to 
its pathology, and adds to our current understanding of cardiovascular health. 
2. The mammalian circadian clock 
Circadian rhythms are defined as entrainable biological rhythms having an intrinsic 
periodicity under constant conditions (e.g. lighting conditions or temperature) of 
approximately 24 hours. Circadian clocks are ubiquitous amongst living organisms, and can 
be found across far-reaching taxa, including mammals, birds, lower vertebrates, 
invertebrates, non-animal multicellular organisms, and unicellular organisms (Bell-Pedersen 
et al., 2005). Among mammals, circadian clocks have been studied in numerous strains (both 
“normal” and pathological) of rodents, primarily in mice, rats, and hamsters, as well as 
other model systems, including humans (Martino and Sole, 2009).  
These studies, along with studies of other vertebrate models (Bell-Pedersen et al., 2005), 
have demonstrated that numerous semi-autonomously operating clocks reside within a 
single mammalian organism. These clocks are distributed amongst most organs and tissues 
of the body, and can be reduced to the level of the individual cell (Stratmann and Schibler, 
2006). These countless cellular clocks are biochemically coupled to produce coherent outputs 
at the tissue and organ levels, and govern a vast array of documented biochemical and 
physiological processes, including sleep-wake cycles, body temperature, metabolism, and 
cardiovascular functions to name a few.  
2.1 Central physiological clocks 
At the organismal level, central neural and peripheral clocks are organized in a hierarchical 
fashion, with intercellular communication being mediated by both neural and humoral 
mechanisms (Stratmann and Schibler, 2006). At the top of this hierarchy is the neurocephalic 
circadian axis, consisting of the hypothalamic suprachiasmatic nuclei (SCN) at its heart, 
along with the optic retinae and the epithalamic pineal gland (Bell-Pedersen et al., 2005).  
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The SCN, at the top of this neurohumoral triumvirate, is regarded as the “master 
pacemaker”, as it synchronizes peripheral oscillators and dictates the appropriate phasing of 
“slave oscillators” subject to the regulatory arms of the central circadian axis. Consistent 
with the SCN’s role as master pacemaker, its ablation abolishes multiple physiological and 
biochemical processes in multiple model species (Turek, 1985), and in rats loss of rhythms 
can be rescued by transplantation of intact SCN from donor rats (Ralph et al., 1990). 
Importantly, the period of host activity rhythms is imposed by the period of the donor 
animal in transplantation studies. Specifically, cardiovascular rhythms are under control of 
the SCN, as ablation of SCN abolishes rhythms in both blood pressure (Weaver, 1998) and 
heart rate (Warren et al., 1994) in rodents. 
In vitro, individual cells of the SCN are capable of sustaining rhythms of multiple clock 
controlled outputs, including action potential firing rate, neuropeptide release, glucose uptake, 
and rhythms of gene expression (Bell-Pedersen et al., 2005; Quintero et al., 2003; Welsh et al., 
1995). Intercellular coupling mechanisms within the SCN are unknown, though pathways 
coupling the SCN with other organs have been described. The SCN is part of a neuroendocrine 
feedback loop between the eyes and pineal gland, and these mutual interactions are necessary 
for entrainment or reinforcement of the hypothalamic clock.  
 
 
Fig. 1. Neuroendocrine pathways involving the SCN 
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As Figure 1 shows, light entrains the SCN via neural connections from the retinohypothalamic 
tract (RHT). In mammals, the SCN (and perhaps the retinae) is the only oscillator that is 
directly entrainable by light, although the pineal gland of many other vertebrate species is 
directly photoreceptive (Bell-Pedersen et al., 2005). The mammalian pineal, while not directly 
photosensitive, influences SCN activity by nightly secretion of the indoleamine hormone 
melatonin. The SCN is rich in melatonin receptors, and its activity is thus inhibited by 
melatonin during the dark period (Cassone et al., 1987). The neurohumoral feedback loop is 
closed by a polysynaptic pathway as follows. First order GABAergic neurons from the SCN 
synapse with neurons in the paraventricular nucleus (PVN) of the hypothalamus. Descending 
tracts from the PVN innervate targets in the intermediolateral cell column of the thoracic 
spinal cord, which in turn project to the superior cervical ganglia (SCG). Finally, sympathetic 
SCG neurons form noradrenergic synapses with the pineal gland, which possesses stimulatory 
2 adrenergic receptors (Moore, 1996). 
The SCN regulates other peripheral organs (including the heart) by way of different 
autonomic efferents. In addition to sympathetic regulation by way of the IML, alternate SCN 
controlled efferent pathways arising from the PVN regulate parasympathetic ganglia by 
projecting to neurons in the dorsal motor nucleus of the vagus (DMV). It appears that 
separate populations of pre-autonomic cells in the SCN provide discreet control over 
symapathetic and parasympathetic pathways (Buijs et al., 2003). 
2.2 Peripheral clocks 
Previously it was believed that the master pacemaker within the SCN drove downstream 
oscillations in other tissues throughout the body, and that the molecular clockworks that 
underlie oscillator function were confined to this tissue. This view was largely based on 
studies which measured disruption of behavioural and physiological outputs of the 
organismal clock, and disruption of molecular rhythms in some tissues. It is now known 
that most tissues possess the same basic molecular machinery (i.e. “clock genes”) as the 
hypothalamic pacemaker, and that many tissues (including the heart) can maintain 
functional oscillations in gene transcription and other processes in a semi-autonomous 
manner (Damiola et al., 2000; Oishi et al., 1998; Stratmann and Schibler, 2006). 
Clock gene oscillations have been maintained in some peripheral tissues for periods of up to 
20 days in culture, indicating a functional molecular clock is preserved ex vivo (Yoo et al., 
2004). Other experiments have demonstrated that clock gene rhythms are not abolished in 
peripheral organs by SCN lesions, but that organs lose synchrony with one another, leading 
to altered phase relationships and disrupted coherent output in vivo (Guo et al. 2005, 2006; 
Yoo et al., 2004). Moreover, implementation of a restricted feeding paradigm (RF) competing 
with light cycles can uncouple rhythms in heart and liver from the SCN, without affecting 
the phase of the SCN itself (Damiola et al., 2000; Hara et al., 2001; Stokkan et al., 2001). As a 
result of these and other studies, the current prevailing view of the SCN as the body’s 
circadian pacemaker is that its role is to synchronize, or entrain, functional peripheral 
oscillators throughout the body, rather than drive them directly. 
2.3 Entrainment of peripheral clocks 
As entrainable oscillators, peripheral tissues may be synchronized by neural or humoral 
signals, or by non-photic exogenous factors such as nutrient intake. Models using parabiosis 
between intact and SCN-lesioned mice demonstrate that some tissues, such as liver, can be 
entrained by humoral (or other non-neural) factors (Guo et al., 2005). Surpisingly, neither 
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implantation of SCN tissue grafts nor non-neural cues from parabiotically linked mice are 
sufficient to rescue clock gene rhythms in other tissues, including cardiac tissue (Guo et al., 
2005, 2006). 
Food intake is a powerful zeitgeber for some peripheral tissues including the heart 
(Balsalobre et al., 2000; Le Minh et al., 2001; Stratmann and Schibler, 2006), and the heart can 
be regulated in discordance with the SCN under a restricted feeding schedule. The 
mechanism of food entrainment likely involves metabolic feedback into the transcriptional 
clock gene cycles, which in turn regulate multiple metabolic processes (Koshaka and Bass, 
2007). Cellular redox state is known to modulate transcriptional clock gene regulation, and 
this may represent one or more pathways by which feeding induced metabolic changes can 
regulate the heart and other clocks (Rutter et al., 2001). 
Plasma glucocorticoid levels are rhythmic in mammals (Stratmann and Schibler, 2006), and 
glucocorticoid signaling interacts with metabolic entrainment (Le Minh et al., 2001). Moreover, 
glucocorticoids are capable of phase shifting molecular rhythms in cardiac tissue and other 
peripheral tissues (Balsalobre, 2000). Plasma levels of epiniphrine and norepinephrine (NE) 
also show diurnal rhythms in humans (Sauerbier et al., 1977), and NE can entrain circadian 
clocks within cultured rat cardiomyocytes  (Durgan et al., 2005). Thus, glucocorticoids, 
especially cortisol in humans, as well as catacholamines, represent other potential zeitgebers 
for peripheral oscillators. These may provide important mechanisms by which the SCN exerts 
control over the heart and other tissues (Stratmann and Schibler, 2006).  
Nightly melatonin secretion by the pineal represents another humoral regulatory arm of the 
circadian system, though extra-pineal contributions to plasma melatonin levels are not fully 
characterized in mammals (Huether, 1993). Interestingly, recent evidence demonstrates 
mammalian cardiac tissue possesses active biosynthetic machinery necessary to produce 
melatonin (Sanchez-Hidalgo et al., 2009), suggesting that extra-pineal melatonin derived 
from cardiac tissue may act as a local autocrine or paracrine signal. 
Numerous beneficial cardioprotective effects have been reported for melatonin (Reiter and 
Tan, 2009). Cardiovascular tissues express both MT1 and MT2 melatonin receptors 
throughout the body, and cardiomyocytes express membrane bound melatonin receptors 
both in vivo and in vitro (Pang et al., 1993; Peliciari-Garcia et al., 2011). The nuclear melatonin 
receptor RORa has been localized to heart as well (Naji et al., 2004), and cardiovascular 
modulation of heart rate in primates may involve activation of intracellular MT3 receptor 
quinone reductase 2 (QR2) (Inui and Hazeki, 2010). Because melatonin exerts non-receptor 
mediated effects on target tissues as well (as a powerful anti-oxidant and scavenger of free 
radicals), it is unclear which cardioprotective mechanisms may involve receptor-dependent 
or receptor-independent regulation.  
2.4 Cellular and molecular clocks 
The mammalian intracellular circadian clock is composed of a finely tuned molecular 
feeback loop (Figure 2). The major components of this feedback loop consist of “clock gene” 
products that either activate expression of other genes (positive elements) or inhibit gene 
expression (negative elements). The primary positive elements are encoded by the genes 
clock and bmal1 (brain and muscle ARNT-like protein 1); these gene products contain a basic 
helix-loop-helix Per-ARNT-Sim (bHLH/PAS) domain, which allow them to heterodimerize 
in the cytoplasm, after which they translocate into the nucleus to activate gene transcription. 
CLOCK:BMAL1 heterodimers activate transcription of target genes (including other “clock 
genes” as well as “clock controlled genes”, or “ccg’s”) by binding to consensus E-box 
sequences in their promoters (Muñoz and Balor, 2003). 
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Fig. 2. Model of the intracellular molecular clock. 
Two important targets of CLOCK:BMAL1 activation are the “negative” clock genes, period 
(per) and cryptochrome (cry). These phylogenetically conserved genes are preserved as core 
clock genes, although multiple mammalian orthologs of these genes have arisen as a result 
of gene duplications (Bell-Pedersen et al., 2005). Indeed, mammalian clock genes include 
three different period genes (per1, per2, and per3) and two cryptochrome genes (cry1 and cry2). 
PER and CRY proteins heterodimerize in the cytoplasm and are then translocated into the 
nucleus, where they inhibit transcriptional activation by the CLOCK:BMAL1 complex. The 
negative elements close the loop, and robustness of the oscillations is enhanced by the 
positive limb. Accurate timekeeping is required to generate a ~24 hour period, and this 
requires precise timing of the feedback loop kinetics. This is mediated in part by the gene 
products of casein kinase 1 epsilon (CK1) and casein kinase 1 delta (CK1), which regulate 
stability and translocation of the PER:CRY complex via modulation of the PER 
phosphorylation state.  
Redundancy is built into the circadian transcriptional loop by the presence of multiple 
functional isoforms of period and cryptochrome genes, as well as the gene for neuronal PAS 
domain protein2 (npas2), whose protein product can substitute for CLOCK as a BMAL1 
dimerization partner in some tissues (Reick et al., 2001). It is unclear what specific roles 
these partially redundant clock genes may have, however, and per3 does not appear to be 
necessary for sustainment of the intracellular transcriptional oscillator (Ko and Takahashi, 
2006). A fascinating study by Qi and Boatang showed that CLOCK protein localizes to the 
Z-disk of the cardiomyocyte sarcomere, and that translocation of CLOCK between the 
nucleus and cytoplasm is influenced by the activity of cross-bridge cycling (Qi and Boateng, 
2006). Thus, cardiomyocyte activity may feed back into the core clock mechanism itself.   
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A secondary feedback loop is formed by activation of CLOCK:BMAL1 targets rev-erb (an 
orphan nuclear receptor member) and rora (retinoic acid-related orphan nuclear receptor). REV-
ERB and RORA proteins competitively bind to retinoic acid-related orphan receptor 
response elements (ROREs) in the promotor of bmal1. These proteins have antagonistic 
functions, such that REV-ERB represses bmal1 transcription while RORA activates it. 
Furthermore, the kinetics of these protein activities differs, such that bmal1 repression by 
REV-ERB occurs more immediately, followed by a delayed activation by RORA (Ko and 
Takahashi, 2006). This secondary feedback loop is thought to stabilize the core 
transcriptional oscillator involving the period and cryptochrome genes (Preitner et al., 2002). 
Importantly, rev-erb and rora genes have been shown to regulate pathways involved in 
cellular metabolism, which may have important consequences for cardiometabolic 
pathologies. These mechanisms are discussed in detail later. A third feedback loop (not 
illustrated) is based on transactivation of the dec1 and dec2 genes by the CLOCK:BMAL1 
complex, followed by inhibition of CLOCK:BMAL1 by DEC1 and DEC2 proteins. 
Most of this ensemble of clock genes has been shown to be rhythmically expressed in hearts 
of mammals and other animals (Cahill, 2002; Chong et al., 2003; Dardente, 2007), and clock 
gene mRNA rhythms have recently been measured in human hearts for per1, per2, and 
bmal1, but not cry1, which appears to be arrhythmic. (Leibetseder et al., 2009). Interestingly, 
the phases of clock gene mRNAs do not necessarily predict the phases of clock controlled 
outputs, and the phase angles between the core oscillator and outputs may be tissue specific 
(Karaganis et al., 2009).  
Because the heart contains multiple cell types, including cardiomyocytes, epithelial cells, 
fibroblasts, and adipocytes, in vivo cardiac clock gene expression could reflect contributions 
of any one (or combinations) of these cell types. Indeed, functional clocks have been 
described in endothelia (Dermot et al., 2007; Takeda et al., 2007), adipose tissue (Zvonik et 
al., 2006), and fibroblasts (Welsh et al., 2004). However, rhythmic clock gene expression 
persists in vitro in isolated rat cardiomyocyte cultures (Durgan et al., 2005; Peliciari-Garcia, 
2011), demonstrating the presence of a functional cardiomyocyte clock.    
Intrerestingly, exogenously administered melatonin alters circadian expression of rev-erb 
mRNA in rat cardiomyocyte cultures (Peliciari-Garcia et al., 2011). In addition to the 
membrane bound melatonin receptors, RORA has been described as a functional nuclear 
melatonin receptor, and may provide an important link between melatonin and regulation 
of peripheral oscillators, including the heart (Peliciari-Garcia et al., 2011). Other ROR 
members, including ROR, may play in important role in peripheral oscillators as well (Ko 
and Takahashi, 2006). 
2.5 The cardiac circadian transcriptome 
Modern technology utilizing high density microarrays to report global gene transcription in 
murine models has tremendously expanded our understanding of the extent to which the 
circadian clock may regulate cellular function. Several laboratories have conducted 
microarray analyses to explore global cardiac gene expression in various normal and 
pathological murine models (Bray et al., 2008; Martino et al., 2007; Storch et al. 2002). The 
first such study to be conducted compared the circadian transcriptome between mouse heart 
and liver, and found that ~8% of cardiac genes (or 462 genes represented on the array) 
exhibited circadian oscillations (Storch et al. 2002). Other studies have yielded similar but 
more extensive estimates (up to 13% of heart genes rhythmic), or lower estimates (2-5% 
heart genes rhythmic) where greater stringencies were imposed on the analysis (Bray et al., 
2008; Martino et al., 2007).   
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Gene ontology analysis from these studies reveals regulation across a wide array of 
molecular pathways, from genes involved in metabolism to cellular trafficking and cell 
death, to name a few. Surprisingly, although ~10% of genes were shown to be rhythmic in 
the liver (Storch et al., 2002), and these included similar functional gene categories as in the 
heart, there was very little overlap between individual genes showing circadian expression 
patterns in both tissues. In fact, only 39 genes showed similar circadian regulation in both 
heart and liver (Storch et al., 2002). This surprising result, along with microarray analyses of 
clock controlled transcriptomes in other tissues and organisms (Bailey et al., 2004, 2007; 
Duffield, 2003; Karaganis et al., 2008), have demonstrated that circadian regulation of gene 
transcription is both extensive and divergent. A key concept which has emerged from these 
studies is that circadian regulation of intracellular pathways is highly specific, and likely 
tuned to the particular demands and functions of a given tissue or organ. As we’ve seen, the 
heart is no exception.   
Subsequent studies of murine cardiovascular tissue have confirmed and extended these 
observations, demonstrating that global regulation of clock controlled genes is divergent 
between closely related tissues or within different functional regions of the same organ (Bray 
et al., 2008; Martino et al., 2007). Separate analysis of rhythmic gene expression in atria and 
ventricles of mouse heart has demonstrated a surprising divergence in the apparent number of 
clock controlled genes expressed within these two tissues (Figure 3). In this study, which 
utilized mutants with cardiomyocyte specific clock disruption to identify intrinsically 
regulated ccg’s (more on this later), 548 genes exhibited circadian transcriptional rhythms in 
the atria, compared to 176 genes in the ventricles (Bray et al., 2008). 
 
 
Fig. 3. Gene ontology of circadian regulated genes from atria and ventricles. From: Bray, et 
al., (2008). Disruption of the Circadian Clock Within the Cardiomyocyte Influences 
Myocardial Contractile Function, Metabolism, and Gene Expression. American Journal of 
Physiology. Heart and Circulatory Physiology,Vol. 294, pp.H1036–H1047, ISSN 1522-1539 
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Many of these genes could be expected to influence normal and pathological aspects of 
cardiophysiology, including genes affecting metabolism, contractile function, and cell 
growth or remodeling. It is worth mentioning a word of caution when interpreting the 
functional significance of these studies, however, since the behaviors of oscillating 
transcripts do not necessarily predict that final gene products will have similar protein 
expression profiles. Posttransciptional and posttranslational regulatory mechanisms, such as 
phosphorylation and ubiquitination may also be under clock control. The final relative 
phasing and amplitudes of protein expression may therefore arise from a complex interplay 
between regulatory pathways involving kinetics of gene transcription and translation, as 
well as mRNA and protein turnover via stability and degradation pathways. This point is 
highlighted by an important study conducted by the Hastings lab, which discovered 
extensive differences between circadian regulated transcription and protein levels in the 
mouse liver (Reddy et al., 2006). For instance, this study revealed that up to 20% of the 
hepatic proteome was rhythmic, while mRNA levels were rhythmic for less than half the 
number of these genes. Clearly, circadian regulation at the transcriptional level is an 
important mechanism of regulation by tissue clocks, but caution must be taken when 
extrapolating these findings to the protein level.  
3. Circadian cardiovascular physiology and pathology 
The circadian system regulates numerous cellular and molecular processes of cardiovascular 
function, including blood pressure, heart rate, contractility, vasomotor tone, blood clotting, 
and cardiovascular metabolism (Sole and Martino, 2009). It is presumed that normal 
function of these processes is necessary to maintain optimal health and longevity, and that 
disruption of circadian regulation of these processes can lead to both acute and chronic 
pathologies, some with potentially disastrous consequences. This section will describe some 
of the major features of cardiovascular function and pathology that may be regulated by the 
circadian clock.  
Because other rhythmic environmental exposures and behaviours may drive physiological 
rhythms with similar periodicities maintained by the circadian clock, it is possible that some 
~24 hour cardiovascular rhythms are not a result of circadian control (i.e., are not 
endogenously maintained rhythms). Moreover, because of the hierarchical organization of 
the organismal circadian system, measurable outputs may reflect different levels of control, 
ranging from local intrinsic oscillator function to systems level control by the neurohumoral 
arms of the SCN and other components of the circadian system.  
Indeed, it is likely that many rhythmic processes of the cardiovascular system reflect 
combinatorial interactions between multiple oscillating systems, both intrinsic and extrinsic. 
For instance, platelet aggregability, a likely predisposing factor for acute ischemic 
cardiovascular incidents, is elevated as a result of morning standing and ambulation, but is 
not increased in the absence of morning activity (Andrews et al., 1996; Brezinski et al., 1988). 
In contrast, other predisposing factors for cardiac ischemia, such as oscillating fibrinolytic 
activity of endolthelial cells, may be regulated by circadian oscillators both intrinsic and 
extrinsic to the heart (Maemura et al, 2000).  
3.1 Temporal variation in the timing of acute cardiovascular events 
Several acute types of pathological cardiovascular events present in a circadian fashion. For 
example, the incidence of myocardial infarction in humans is much higher in the morning 
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hours, peaking between 06:00-12:00, just as patients arise from bed, or soon before or after 
doing so (Cohen et al., 1997; Muller et al., 1985). In contrast, the incidence of infarcts reaches 
a nightly trough during the hours between 03:00-06:00. Overall, infarcts are approximately 
three fold more likely to occur during the morning than during night. 
Other related cardiovascular events that peak in the early or late morning hours include 
deadly ventricular arrhythmias (Tofler et al., 1995), defibrillation threshold (Venditti et al., 
1996) atrial and ventricular refractoriness (Kong et al., 1995; Simantirakis et al., 2001), 
ischemic stroke (Argentine et al., 1990), rupture of aortic aneurysm or aortic dissection 
(Manfredini et al., 2004; Mehta et al., 2002; Sumiyoshi et al., 2002) and sudden cardiac death 
(Mahmoud at al., 2011; Muller et al., 1987). Some cardiovascular events, such as atrial 
arrhythmias (Deguchi et al., 2009; Sandberg et al., 2010) or thromboembolic stroke (Marshal, 
1977) may peak at other times of day. Comorbid conditions, such as obstructive sleep apnea 
(OSA), may influence the timing of cardiovascular events, and contribute to pathological 
circadian disruption (Kuniyoshi et al., 2008). 
3.2 Circadian regulation of heart rate and blood pressure 
Heart rate (HR) and blood pressure (BP) both exhibit diurnal rhythms in humans, peaking 
the during the day when humans are active, or during the active nocturnal phase in rodent 
models (Mansoor et al., 1994; Millar-Craig et al., 1978; Reilly et al., 2007; Weber et al., 2002). 
HR and BP are lowest during nighttime, but begin to rise in the early morning hours in 
anticipation of waking. These rhythms coincide with rhythms in autonomic tone, with the 
sympathetic system dominating during the day, and the parasympathetic system 
dominating at night. The adaptive value of these daily rhythms is obvious, in that elevated 
HR and BP allow the body to carry out the physical demands associated with daily 
activities, while a nightly reduction in the levels of these processes allows the sleeping body 
to save energy and shift its focus to other important demands, such as cellular upkeep, 
tissue remodelling, or other restorative processes (Sole and Martino, 2009). Importantly, the 
timing of these cardiovascular rhythms is slightly phase advanced relative to the 
sleep/wake cycles (i.e. cardiovascular rhythms anticipate transitions between activity 
phases), allowing for a smooth transition between these alternating states.  
The importance of maintaining these diurnal cardiovascular rhythms is evident when 
comparing variants of hypertensive patients, known as “dippers” and “non-dippers”. In 
some hypertensive patients (“dippers”), normal amplitude circadian rhythms are 
maintained, albeit over an elevated baseline. Other hypertensive patients, so called “non-
dippers”, express a continuously high blood pressure through the active and sleep phases. 
This latter group, having disrupted blood pressure rhythms, are at greater risk for 
developing other cardiovascular diseases and suffering organ damage (Mancia and Parati, 
2000; Verdicchia et al., 1990, 1993). Classification of hypertensive patients as non-dippers is 
based on having less than a 10% decrease in blood pressure at night, since most 
normotensive patients exhibit a >10% change. Some studies, however, have shown that 
blood pressure rhythm amplitudes are distributed normally throughout a given population, 
indicating that a 10% threshold is an arbitrary cutoff value (Mancia and Parati, 2000).  
Other important, related cardiovascular changes exhibit daily rhythms as well, including 
vascular resistance and tone, although studies have produced conflicting results about how 
vascular resistance changes throughout the day (Elherik et al., 2002; Kawano et al., 2002; 
Otto et al., 2004; Shaw et al., 2001), and differential, tissue specific vasomotor control may 
occur throughout the body. 
www.intechopen.com
 
Non-Ultradian Cardiac Rhythms: Circadian Regulation of the Heart 
 
77 
4. Evidence linking cardiovascular rhythms and pathology with intrinsic 
oscillators 
It is unclear to what extent daily variations in heart rate and blood pressure are due to 
intrinsic cardiac oscillators or exogenous factors. Because peripheral vascular clocks have 
been described (Dermot et al., 2007), and given the presence of circulating zeitgebers (Guo et 
al., 2004), it is possible that many rhythms of normal and pathological cardiovascular 
function can be attributed to these dispersed signals or to behavioural patterns. Until 
recently, diurnal rhythms in acute cardiovascular events have been attributed solely to the 
stress of awakening and the accompanying morning surge in blood pressure. In light of the 
discoveries of intrinsic cardiovascular clocks, however, these phenomena are currently 
being re-examined, and it is now clear that at least some of these diurnal pathologies result 
from a contribution of local, intrinsic circadian regulation. 
4.1 Lessons from clock mutants 
Several studies have shown disrupted cardiovascular rhythms in animal models possessing 
mutations in core clock gene components. For example, heart rate (HR) and arterial blood 
pressure (BP) rhythms (assayed by radiotelemetry) are abolished in bmal1 knockout mutants 
(bmal1-/-) even a under light:dark (LD) cycle, and bmal1-/- mice are hypotensive (Curtis et al., 
2006). On the other hand, dominant negative clock19 mutants express a less severe 
phenotype, showing partial disruption of HR and BP rhythms (Curtis et al., 2006). 
Disruption of the negative limb of the core molecular clock also disrupts cardiovascular 
rhythms, as baseline rhythms in HR and BP (measured by vascular pressure transducers) 
were lost in both cry1-/- and cry2-/- mice under free-running conditions in constant darkness 
(Masuki et al., 2005). 
Because these mutants have deficient clocks in all tissues, including the SCN, it is impossible 
to determine through these studies whether loss of intrinsic cardiac oscillators contribute to 
these phenotypes. To resolve this issue, ME Young and colleagues have generated mutant 
mice containing a cardiomyocyte-specific clock19 mutation, called CCM mice. By comparing 
various measures of cardiac function and global gene expression between wild type and 
CCM mice in vivo and ex vivo, this group has identified multiple putative pathways through 
which the intrinsic cardiomyocyte clock might regulate cardiovascular function and 
dysfunction (Bray et al., 2008; Durgan et al., 2006).  
For example, in vivo heart function is altered in CCM mice, which show diminished HR 
rhythms, sinus brachycardia, reduced cardiac output, and other functional differences (Bray 
et al., 2008). Experiments utilizing an ex-vivo cardiac perfusion system demonstrate the 
normal heart undergoes circadian rhythms in cellular metabolism and contractile function in 
response to cardiac workload (Durgan et al., 2007). CCM mice show abolished rhythms in 
triglyceride synthesis, reduced cardiac efficiency, and chronically elevated fatty acid 
oxidation (Bray et al., 2008). Additionally, while normal hearts exhibit an increased 
responsiveness to fatty-acids during the active period, which persists in vitro, this rhythm is 
abolished in CCM hearts (Durgan et al., 2006). In agreement with this role of the 
cardiomyocyte clock as a regulator of cellular metabolism, genes regulating both lipid and 
glycogen metabolism where found to be regulated by the cardiomyocyte clock (Bray et al., 
2008), and cardiac responsiveness to a high fat diet is altered in CCM mice (Tsai et al., 2009). 
A working model proposed by Young and colleagues is that the cardiomyocyte circadian 
clock gates lipid metabolic pathways to balance -oxidation rates with fatty acid supply in a 
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manner that is appropriate to the time of day. During the active period, when metabolic 
energy requirements are high, transcriptional responsiveness to fatty-acids is increased, 
allowing induction of triglyceride synthesis and fatty acid oxidation. This allows the heart to 
accommodate diurnal changes in circulating fatty-acids levels as a result of feeding or 
fasting status. This elevated transcriptional response at a time of day when fatty acid levels 
are high is necessary, since excess fatty acids can otherwise be shunted into harmful 
“lipotoxic” pathways. Thus, exposing the heart to an excess of lipids at an inappropriate 
time of day (when the transcriptional machinery is not primed for healthy lipid metabolism) 
can cause contractile dysfunction, as in diabetes mellitus (Young et al., 2002).   
Interestingly, rev-erb is known to be an important regulator of lipid metabolism, in 
addition to its role as a core clock gene (Duez and Staels, 2008). It functions to control 
intracellular triglyceride metabolism and -oxidation pathways as well as plasma lipid and 
lipoprotein metabolism. Additionally, rev-erb is implicated as a mediator of vascular 
inflammation, and has been speculated to play a role in the development of metabolic 
disorders, including obesity and diabetes. Rev-erb could therefore contribute to the 
development of cardiovascular pathologies through multiple levels of control    
4.2 Disruption of circadian cycles has cardiovascular consequences 
Shift work has long been hypothesized to be a risk factor for cardiovascular disease and 
other chronic conditions in humans. Shift workers develop a non-dipper blood pressure 
profile and may be at increased risk for hypertension (Mosendane, 2008). Additionally, 
increased risk for metabolic disturbances have been reported for shift workers, including 
dyslipidaemia, metabolic syndrome, and diabetes, although a recent thorough review shows 
epidemiological evidence for metabolic and cardiovascular disease is inconsistent (Wang et 
al., 2011). However, the suggestive evidence warrants further study of these associations.    
The etiology of cardiovascular disease in shift workers, if present, is unknown. While there 
are many confounding factors associated with shift work (such as poor diet and higher 
smoking prevalence), circadian dyssynchrony has logically been proposed as a causative 
factor.  
Several experimental animal studies support the hypothesis that circadian system 
perturbations cause or exacerbate cardiovascular disease and reduce longevity. In one such 
study, cardiomyopathic Syrian hamsters (a model for congestive heart failure) were 
subjected to weekly reversals of LD cycles, resulting in major disruptions of circadian body 
rhythms (Plamen et al., 1998). Rhythm-disturbed animals experienced a median 11% 
decrease in life span compared with controls.  
Hamsters heterozygous for the tau mutation (a point mutation in the CK-1 gene) have 
shortened periods and are unable to entrain properly to a normal 24 hour LD cycle. 
Fascinating studies have revealed that +/tau mutants have reduced longevity under a 
standard photoperiod, and longevity can be rescued in aged hamsters where normal SCN 
tissue has been grafted into the mutant host (Hurd and Ralph, 1998; Ralph and Menaker, 
1988). Interestingly, tau/tau homozygotes are spared these deleterious effects as they cannot 
entrain at all under these conditions and can simply free-run. This observation demonstrates 
that internal desynchronisation of the circadian clock, and not the tau mutation per se, has 
pathological consequences. 
A compelling recent study has demonstrated that mortality in rhythm perturbed +/tau  
hamsters coincides with major cardiomyopathy and renal disease (Martino et al., 2008). 
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Moreover, +/tau animals raised in a shorter photoperiod matching their endogenous period 
phenotype were protected from these deleterious effects, and were clinically no different 
than wild type animals. In addition, this research group showed that lesion of the SCN in 
young mutants protected mice from the onset of pathological cardiac hypertrophy under a 
disruptive light cycle. Collectively, these results provide powerful evidence that internal 
dissonance from the SCN pacemaker is harmful, and indeed worse than complete loss of the 
pacemaker itself.  
Another study by Martino et al. compared global rhythmic gene transcription in heart and 
aorta in normal (sham operated) mice with those in an induced cardiovascular disease state 
(Martino et al., 2007). The rhythmic heart transcriptome was biphasic, as described 
elsewhere (Bray et al., 2008), and was highly similar to the aortic transcriptome, with an 
overall conserved phase angle, but somewhat phase delayed (Figure 4).  
 
 
Fig. 4. Phase plots of circadian transcriptomes in heart and aorta. Reprinted from: Martino, 
et al., (2007). Disturbed Diurnal Rhythm Alters Gene Expression and Exacerbates 
Cardiovascular Disease With Rescue by Resynchronization. Hypertension, Vol.49, pp.1104-
1113, ISSN 1524-4563 
Remarkably, pressure overload induced hypertrophy (via transaortic constriction, or TAC) 
had no apparent effect on global circadian gene transcription in either the heart or aorta. 
However, TAC mice subjected to disruptive photoperiods exhibited abnormal adaptive 
responses to the disease state, such as vascular thinning and muscular atrophy as opposed 
to compensatory hypertrophy in the non-disrupted cohorts. Rhythm disturbed TAC mice 
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also exhibited altered cardiac rhythms of genes important for regulating hypertrophy, blood 
pressure, and fibrosis, as well as altered clock gene rhythms in both the heart and SCN. 
Furthermore, a rescue protocol implementing a restorative photoperiod reversed 
pathological loss of compensatory responses including cardiomyocyte hypertrophy and 
perivascular fibrosis (Martino et al., 2007). Therefore, it must be concluded that the circadian 
clock regulates compensatory cardiac tissue remodeling secondary to the primary 
cardiovascular disease state. 
5. Therapeutic implications and future directions 
5.1 Preventative chronotherapeutic applications 
Our expanding current understanding of the circadian system’s role in regulating 
cardiovascular function should, in principle, open new avenues for chronotherapeutic 
applications. Perhaps the simplest application is chronobiological awareness. All patients, 
and especially those with predisposing health risk factors, may benefit by practicing good 
“sleep hygiene”. This refers to maintaining a regular sleep/wake schedule by going to bed 
and rising at regular times, and ensuring a full night’s sleep. Patients should be screened for 
sleep apnea, which of course should be treated if found.    
Unnecessary phase shifts, for instance due to traveling or late nights out, should be 
minimized. Re-entrainment after disruptive phase shifts, as in jet lag, can be facilitated using 
supplemental melatonin. This may be especially beneficial in frequent travelers. New 
melatonergic agonists, such as, ramelteon and tasimelteon, have different pharmacological 
properties and may provide alternative therapeutic effects. (Singh et al., 2010). The 
availability of alternative treatments offers the promise of individualized chronotherapies.  
If at all possible, shift work should be avoided in patients with cardiovascular disease or 
with strong predisposing factors. If changing hours is not permissible, negative effects 
might be mitigated by chronobiological awareness and focus on making healthy pro-active 
lifestyle choices, such as maintaining proper diet and exercise regimes and undergoing 
regular physical exams. While these are good general preventative recommendations for 
any patient, a greater appreciation for the health benefits of circadian chronosynchrony may 
increase compliance, and can be aided by both an increase in doctor awareness and patient 
education.  
5.2 Chronotherapeutic interventions 
Multiple recent studies have shown a strong time-dependent efficacy for administration of 
anti-hypertensive medications, including beta blockers, calcium channel blockers, 
angiotensin-converting enzyme (ACE) inhibitors, and angiotensin II receptor blockers 
(ARB’s) (Takeda and Maemura, 2010). Chronotherapy was shown to be especially useful in 
patients with resistant hypertension, and more beneficial than changing drug combinations 
(Hermida et al., 2008). Anti-hypertensive chronotherapy, in conjunction with the benefits of 
ambulatory blood pressure monitoring in candidate patients (Mancia and Parati, 2000), 
could provide effective new means of tailoring treatment to subjects with different blood 
pressure profiles.  
Chronic nightly melatonin administration has also been reported to reduce hypertension in 
human male patients (Scheer et al., 2004). In addition to its acute soporific, phase-shifting, 
and anti-hypertensive effects, melatonin has powerful cardioprotective benefits. This may 
be due in part to melatonin’s properties as a potent anti-oxidant, but studies using a 
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perfused rat heart system have demonstrated a possible receptor dependent protection 
against ischemia/reperfusion injury (Genade et al., 2008). Clinical trials are underway to test 
the effectiveness of melatonin in treating human patients with ischemic heart disease 
(Dominguez-Rodriguez, 2007; 2010).  
Mechanisms underlying circadian variation in cardiac arrhythmias are not understood, and 
chronotherapeutic studies for treating cardiac arrhythmias are lacking. However, circadian 
expression of voltage gated K+ channel mRNA and protein levels (for Kkv1.5 and Kv4.2) has 
been detected in rat heart (Yamashita et al., 2003), and more recently for L-type voltage 
gated Ca2+ channels (VGCCα1C and VGCCα1D) in embryonic chick heart (Ko et al., 2010). As 
we gain new understanding of how the cardiomyocyte circadian clock gates 
electrophysiological membrane properties, the way will be paved for the development of 
new chronotherapies targeting cardiac arrhythmias.  
Perhaps the ultimate frontier of circadian chronotherapy lies in gene transfer techniques. 
Although current gene transfer methods are inefficient and risky, the field of gene therapy is 
in its infancy, and should be expected to mature as technical difficulties are resolved. 
Several labs have already employed these methods to treat hypertension in rat models, and 
other models of gene chronotherapy for the treatment of cardiovascular disease are under 
development (Lin et al., 1995, 1998; Murakami et al., 1999; Wang et al., 2004; Yla-Herttuala, 
2000).  
5.3 Future avenues of research 
Much has been learned about the intimate partnership between circadian oscillators and 
cardiovascular health, and much is still to be learned. Fruitful avenues of research have 
employed circadian mutants, animal disease models, and a variety of ex vivo and in vivo 
preparations. Classical circadian research methods, such as surgical grafting, ablation, and 
cycle disruption, have been used to great new effect, in concordance with modern molecular 
tools such as mutant construction, and microarray analysis. This multi-pronged approach 
has revolutionized our understanding of peripheral oscillators, and energized a new 
paradigm for studying systems biology.  
These same approaches and model systems will no doubt continue to produce valuable new 
knowledge, while advanced technologies promise to forge new inroads in the quest to 
unravel cardiovascular clocks. Adaptations of molecular manipulation techniques will allow 
valuable tissue specific knockdown and overexpression experiments to be conducted in 
parallel with genetic knockouts. Tissue and cell specific genetic engineering, side by side 
with improved biological assays, should allow us to continue to dissect the circadian code, 
gene by gene, protein by protein. The circadian proteome must be characterized and 
reconciled with the mosaic of divergent circadian transcriptomes. As new therapies are 
investigated, and epidemiological data are collected, we will continue to bridge the gap 
between laboratory animal and human patient. 
6. Conclusion 
As we’ve seen in this review, circadian rhythms are woven into the dynamic fabric of 
temporal cardiac homeostasis. Governance of this complexly balanced tapestry is shared 
between a synchronous cooperation between distributed, intrinsic oscillators and the master 
pacemaker within the SCN. Discordance between system components can cause 
cardiovascular dysfunction, and exacerbate pre-existing disease. While we continue to 
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unmask the role of circadian rhythms in cardiovascular function, the impetus will increase 
for application of circadian principles into clinical practice. As our fourth dimensional view 
of human medicine matures, we will more clearly see how circadian regulation of the heart 
is an indispensable feature of healthy cardiovascular function.  
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